Mirtazapine Should NOT Be Used for Appetite Stimulation in Elderly Patients with Dementia
The most recent and highest-quality guidelines explicitly recommend AGAINST using drugs to stimulate appetite or weight gain in persons with dementia. 1 This represents a strong consensus position (89% agreement) from 2024 clinical nutrition guidelines. 1
Why Appetite Stimulants Are Not Recommended in Dementia
The evidence against using mirtazapine specifically for appetite stimulation in dementia patients is clear:
No placebo-controlled trials exist demonstrating efficacy of mirtazapine for weight loss in dementia patients without depression. 1
Only one small retrospective study (n=22) using 30 mg daily mirtazapine showed weight gain (mean 1.9 kg at 3 months, 2.1 kg at 6 months), but this was uncontrolled and lacked rigorous methodology. 1
Potentially harmful side effects must be balanced against very uncertain benefits for appetite and body weight. 1
Recent safety data raises serious concerns: A 2021 randomized controlled trial found 7 deaths in the mirtazapine group versus 1 in placebo by week 16 (p=0.065), though this was for agitation treatment. 2
2025 cohort study of 5,409 long-term care residents found mirtazapine associated with higher mortality risk (aHR 1.16,95% CI 1.05-1.29) compared to sertraline. 3
The Only Acceptable Exception
Mirtazapine could potentially be considered ONLY when the dementia patient has comorbid depression requiring antidepressant treatment. 1, 4 In this specific scenario:
- The 2002 Alzheimer's Disease Management Guidelines list mirtazapine as "potent and well tolerated; promotes sleep, appetite, and weight gain" for treating depression in dementia. 5
- Dosing for depression: Start 7.5 mg at bedtime, with a maximum of 30 mg at bedtime. 5
- The appetite-stimulating effect becomes a beneficial side effect rather than the primary indication. 4
What Should Be Done Instead
Address the underlying causes of poor appetite systematically: 1
- Perform medication review by a qualified practitioner to minimize adverse drug effects on food and fluid intake (97% consensus). 1
- Check for cholinesterase inhibitors causing weight loss. 1
- Assess for sedatives reducing attention at mealtimes. 1
- Evaluate for opioids, digoxin, metformin, antibiotics, and NSAIDs affecting appetite. 1
Implement non-pharmacological interventions: 6
- Oral nutritional supplements (ONS) or tube feeding may improve nutritional status in early and moderate dementia. 6
- Encourage shared eating occasions with others to improve quality of life and dietary intake. 1
- Provide feeding assistance, verbal prompting, and supervision during meals. 4
Critical Pitfall to Avoid
Do not prescribe mirtazapine solely for appetite stimulation in dementia patients. The lack of controlled evidence, potential for serious adverse effects including increased mortality, and strong guideline recommendations against this practice make it inappropriate. 1, 2, 3 The 2024 guidelines state unequivocally: "drugs to stimulate appetite or weight gain should NOT be used in persons with dementia." 1